The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition.
about
Overview of Transgenic Mouse Models of Myeloproliferative Neoplasms (MPNs).Hmga2 promotes the development of myelofibrosis in Jak2V617F knockin mice by enhancing TGF-β1 and Cxcl12 pathways.Multifaceted role of the polycomb-group gene EZH2 in hematological malignancies.Myeloproliferative neoplasm stem cells.Dual Targeting of Oncogenic Activation and Inflammatory Signaling Increases Therapeutic Efficacy in Myeloproliferative Neoplasms.Mutations in myeloproliferative neoplasms - their significance and clinical use.
P2860
The loss of Ezh2 drives the pathogenesis of myelofibrosis and sensitizes tumor-initiating cells to bromodomain inhibition.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
The loss of Ezh2 drives the pa ...... lls to bromodomain inhibition.
@en
type
label
The loss of Ezh2 drives the pa ...... lls to bromodomain inhibition.
@en
prefLabel
The loss of Ezh2 drives the pa ...... lls to bromodomain inhibition.
@en
P2093
P2860
P50
P356
P1476
The loss of Ezh2 drives the pa ...... ells to bromodomain inhibition
@en
P2093
Akinori Kanai
Atsushi Iwama
Hironori Harada
Kazuya Shimoda
Makiko Mochizuki-Kashio
P2860
P304
P356
10.1084/JEM.20151121
P407
P577
2016-07-11T00:00:00Z